A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes
NCT ID: NCT01822431
Last Updated: 2013-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Diagnostic Performance of the Indicator Plaster Neuropad for the Detection of Diabetic Autonomic Neuropathy
NCT06734143
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
NCT05546138
To Evaluate if Wide Blood Sugar Fluctuations Lead to Injury of Heart Function and Heart Nerves
NCT01170832
Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
NCT01847937
Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus.
NCT03481374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with type 1 diabetes mellitus
Metaiodobenzylguanidine scintigraphy, Autonomic function tests, Pupillometry, Holter monitoring
metaiodobenzylguanidine scintigraphy
Healthy controls
Autonomic function tests, Pupillometry, Holter monitoring
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
metaiodobenzylguanidine scintigraphy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severe cardiac autonomic neuropathy
* Medications other than insulin
* Ocular disease other than refractive eye disorders
* History of neurologic disease
* History of cardiovascular disease
* Thyroid disease
* Vitamin B insufficiency
* Other possible cause for autonomic failure
20 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AHEPA University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zantidis Anestis
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AHEPA hospital, First Propedeutic clinic of internal medicine
Thessaloniki, Thessaloniki, Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A-Z0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.